Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
NCT ID: NCT02366858
Last Updated: 2017-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-10-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
NCT01815606
Trial Comparing 19 and 25-gauge EUS-FNA Needles
NCT01677312
Comparison of a Novel 22-gauge Core Biopsy Needle
NCT01598194
Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses
NCT02910960
Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis
NCT02078232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
19 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle.
19 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle
22 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle.
19 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle
22 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
19 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle
22 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant women will be excluded. This will be confirmed by self-report
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AdventHealth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shyam Varadarajulu, MD
Role: PRINCIPAL_INVESTIGATOR
AdventHealth
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida Hospital
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
510467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.